Note 2 - Restructuring, Impairment, and Other Charges and Credits	9 Months Ended
Sep. 30, 2022
Notes to Financial Statements
Restructuring, Impairment, and Other Activities Disclosure [Text Block]	2. Restructuring, Impairment, and Other Charges and Credits During the three and nine months ended September 30, 2022, we recorded $138 million and $217 million, respectively, in accelerated depreciation, asset write-offs and other related charges, of which $125 million and $193 million, respectively, were reflected in cost of sales in the consolidated statements of income. The activity primarily related to capacity optimization of an emerging growth business. There were no material restructuring, impairment and other charges and credits for the three and nine months ended September 30, 2021.

Note 2 - Restructuring, Impairment, and Other Charges and Credits

9 Months Ended

Sep. 30, 2022

Restructuring, Impairment, and Other Activities Disclosure [Text Block]

2. Restructuring, Impairment, and Other Charges and Credits

During the three and nine months ended September 30, 2022, we recorded $138 million and $217 million, respectively, in accelerated depreciation, asset write-offs and other related charges, of which $125 million and $193 million, respectively, were reflected in cost of sales in the consolidated statements of income. The activity primarily related to capacity optimization of an emerging growth business.

There were no material restructuring, impairment and other charges and credits for the three and nine months ended September 30, 2021.